Optimizing immunomodulatory therapy for MS patients: an integrated management model.
Jeffery
Douglas
D
Bashir
Khurram
K
Buchwald
Linda
L
Coyle
Patricia
P
Freedman
Mark
M
Markowitz
Clyde
C
Rammohan
Kottil
K
Reder
Tony
T
Sharief
Mo
M
Wolinsky
Jerry
J
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D004358:Drug Therapy / Q000592:standards; D000068717:Glatiramer Acetate; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D000068556:Interferon beta-1a